International Ataxia Rating Scale in Younger Patients

Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy

NCT06321965 ·Status: RECRUITING ·Phase: NA

Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)

NCT04944940 ·Status: RECRUITING

Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia

NCT01958177 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Body Composition and Hormonal Status in Ataxia Telangiectasia

NCT02345200 ·Status: COMPLETED ·Phase: NA

Spinraza in Adult Spinal Muscular Atrophy

NCT03709784 ·Status: ACTIVE_NOT_RECRUITING

Clinical-immunological Features of DNER Ataxia

NCT05225896 ·Status: UNKNOWN

Study of ALS Reversals 2: Genetic Analyses

NCT03464903 ·Status: COMPLETED

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)

NCT02579239 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Characterization of the Clinical-epidemiological Profile of Patients With SMA5q Types II and III: Observational Study

NCT04404764 ·Status: COMPLETED

Methodology Study of Novel Outcome Measures to Assess Progression of ALS

NCT02611674 ·Status: COMPLETED

Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy

NCT02391831 ·Status: COMPLETED ·Phase: NA

Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia

NCT03357978 ·Status: UNKNOWN ·Phase: NA

Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis

NCT00023075 ·Status: COMPLETED

Cortico-Spinal tDCS as Rehabilitative Intervention in Amyotrophic Lateral Sclerosis

NCT04293484 ·Status: COMPLETED ·Phase: NA

Study of Hepatic Function in Patients With Spinal and Bulbar Muscular Atrophy

NCT02124057 ·Status: COMPLETED

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia

NCT01360164 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Real World Clinical Effectiveness & Safety of Vesemnogene Lantuparvovec for Spinal Muscular Atrophy (SMA) in Low-middle Income Countries (LMIC).

NCT07265232 ·Status: RECRUITING ·Phase: PHASE3

Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)

NCT00468832 ·Status: UNKNOWN

A Pilot Study of Biomarkers for Spinal Muscular Atrophy

NCT00756821 ·Status: COMPLETED

Prospective Follow-up of Patients With Glycogen Storage Disease Type III

NCT01563705 ·Status: UNKNOWN ·Phase: NA

Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy

NCT06562283 ·Status: RECRUITING ·Phase: NA

Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)

NCT02836418 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral Sclerosis

NCT01992029 ·Status: TERMINATED

Study of ATH434 in Participants with Multiple System Atrophy

NCT05109091 ·Status: COMPLETED ·Phase: PHASE2

Effect of Functional Exercise in Patients With Spinal Bulbar Muscular Atrophy

NCT01369901 ·Status: COMPLETED ·Phase: PHASE1/PHASE2